Abstract
In this study, nine different C-2 aroyl imidazole derivatives were synthesized in a one pot reaction with two steps, and the reduction reactions of these derivatives with NaBH4 were carried out under mild conditions. Substitution reaction of obtained imidazo methanol derivatives with chloroacetylchloride reagent and ring reaction of substitution products were investigated. It was determined that 1,4-imidazoxazinone derivative was obtained as a result of the cyclization reaction. The intermediate products obtained during the cyclization reaction were isolated, and the path of the reaction under different conditions was discussed.
Keywords: Cyclization, imidazole, imidazoxazinone
1. Introduction
Imidazole ring is an essential heterocyclic compound containing two nitrogens in its structure. In literature studies, it is seen that imidazole compounds are used in various fields such as biomimetic catalysts [1–3], medical drugs [4], artificial receptors [5], agricultural chemicals [6], sensors [7], supramolecular ligands [8], and batteries [9]. The imidazole ring contains an acidic proton as well as a nitrogen atom with a basic character. Due to this feature, the zwitterionic structure provides sensitivity like an ionic structure [10]. Thanks to this feature of imidazole compounds, it is possible to break the NH proton in the imidazole ring with various bases and to obtain heterocyclic structures containing imidazole ring by substitution with various reagents [11–14]. Imidazole, a member of the electron-rich azole family, can bind to proteins with weak interactions. Due to such properties, it shows a wide range of biological activity in biological systems through coordination, ion-dipole, cation-π, π-π interaction, and Van der Waals interactions [15,16].
Nowadays, drugs such as oxiconazole, clotrimazole, etc. are drugs that contain imidazole in their structure and are used to treat various diseases [17]. Although imidazole-based heterobicyclic compounds are essential structures, imidazole-2-aroyl derivatives and the structures of these derivatives such as imidazoxazinone derivatives with various reagents have hardly been investigated. Recently, great effort has been put into developing new, effective, biologically active substances to obtain important heterobicyclic molecules such as imidazoxazines. Imidazoxazines (Figure 1) have some critical activities such as tuberculosis (R-PA-824) [18], anxiety, depression, and anticancer (GSK-588045) [19]. Another important imidazole derivative known to have biological activity is imidazoxazole (CGI-17341) [20].
Figure 1.

Some important heterocyclic compounds, including imidazoxazine and imidazoxazole
This study aims to create practical approaches to synthesize heterobicyclic molecules with imidazole rings having different unknown structures and investigate their chemistry in detail. Although there are many examples of imidazole derivatives, the synthesis of imidazoxazinone 5 derivatives (Figure 2), which is not included in the literature, has been investigated. While there are many reaction pathways to obtain imidazole ring, we have utilized the aryglyoxal starting from aryl-acetyl compounds, which was reacted with SeO2. Arylglyoxals are very critical starting materials for different types of heterocyclic molecules such as oxiran, β-lactam, pyrrolidine, pyrrole, and pyrazole [21–23]. In addition, we performed the isolation of the intermediate products during the cyclization reactions, and the path followed by the reaction was also discussed.
Figure 2.

Imidazoxazinone 5.
2. Experimental
2.1. Materials and methods
Solvents were dried by refluxing with appropriate drying agents and were distilled before use. Melting points were determined using an Electrothermal Gallenkamp apparatus and are uncorrected. FT-IR spectra were obtained in ATR mode using a Thermo Nicolet iS10. Elemental analysis was carried out using a Thermo Scientific Flash 2000. 1H-NMR and 13C-NMR spectra were recorded using a 400 MHz Agilent using TMS (tetramethylsilane) as the internal standard. All experiments were followed by TLC (thin layer chromatography) using DC Alufolien Kieselgel 60 F254 (Merck) and a Camag TLC lamp (254/366 nm). Commercially available chemicals were purchased from Merck, Aldrich, ABCR and Alfa Easer Co.
2.2. General procedure 1
Acetophenone (1mmol) 1 derivatives were dissolved in 30 mL of 1,4-dioxane in a 100mL flask. SeO2 (2.5 mmol) was added and refluxed. The course of the reaction was followed by TLC (thin layer chromatography). The reaction was seen to be finished after 24 h. The reaction was filtered, and 20mL of dissolved ammonium acetate (5 mmol) was added and stirred at room temperature. After determining the completion of the reaction by TLC method, the reaction was filtered with ice water for half an hour and dried. As a result, C-2 aroyl substituted imidazole derivatives 2 were obtained.
2.3. General procedure 2
C-2 aroyl substituted imidazole derivatives 2 (1 mmol) were dissolved in 30 mL of methanol, and NaBH4 (3 mmol) was added, and it was understood that the reaction was completed after 24 h by TLC method. It was extracted with ethyl acetate and water (30X50). It was dried with MgSO4 and evaporated. The column chromatography purified the crude product with eluent ethyl acetate / n-hexane 1/5. The C-2 aroyl substituted imidazolo methanol 3a-i derivatives were obtained.
2.3.1. Phenyl(4-phenyl-1H-imidazol-2-yl)methanol(3a) [24]

Yield; 73%, Color; white solid. m.p: 170–172°C
FT-IR(ATR cm–1): 3210, 3053, 2833, 2678, 2050, 1888, 1608, 1588, 1511, 1496, 1480, 1458, 1435. 1H NMR (400 MHz, d-DMSO) δ = 12.10 (s, 1H, N-H), 7.74–7.72 (m, 2H, Ar-H), 7.47–7.45 (m, 3H, Ar-H), 7.34–7.28 (m, 4H, Ar-H), 7.25–7.21 (m, 1H, Ar-H), 7.16–7.12 (m, 1H, Ar-H), 6.27 (d, J= 2.08 Hz, 1H, OH), 5.79 (s, 1H, CH).13C NMR (100 MHz, d-DMSO) δ= 151.3, 143.5, 128.8, 128.5, 127.6, 126.9, 126.4, 124.6, 70.1. LC-MS/MS Anal.Calcd. for C16H15N2O [M+H]: 251.11789, Found: 251.11841.
2.3.2. (4-Methoxyphenyl)(4-(4-methoxyphenyl)-1H-imidazol-2-yl)methanol(3b) [24,25]

Yield; 80%, Color; white solid. m.p: 166–168°C
FT-IR(ATR cm–1): 3162, 3008, 2961, 2835, 2626, 2037, 1609, 1585, 151568, 1511, 1488, 1455, 1425. 1H NMR (400 MHz, CDCl3) δ = 11.9 (s, 1H, NH), 7.73–7.61 (m, AA’ part of AA’BB’ system, 2H, Ar-H), 7.34-7.32 (m, 3H, Ar-H), 6.87–6.85 (m, BB’ part of AA’BB’ system, 4H, Ar-H), 6.08 (d, J= 3.8 Hz, 1H, OH), 5.68 (d, J= 3.8 Hz, 1H, CH), 3.72 (s, 3H, OCH3), 3.70 (s, 3H, OCH3). 13C NMR (100 MHz, CDCl3) δ= 158.8, 158.0, 151.2, 139.7, 135.7, 128.1, 125.8, 114.2, 113.8, 111.5, 69.7, 55.5, 55.4. LC-MS/MS Anal.Calcd. for C18H19N2O3 [M+H]: 311.13902, Found: 311.13937.
2.3.3. (4-Iodophenyl)(4-(4-iodophenyl)-1H-imidazol-2-yl)methanol(3c)

Yield; 40%, Color; red solid. m.p: 270°C
FT-IR(ATR cm-1): 3201, 2050, 1980, 1908, 1653, 1587, 1526, 1482. 1H-NMR (400 MHz, CDCl3) δ = 7.46–7.42 (m, AA’ part of AA’BB’ system, 4H, Ar-H), 7.26–7.23 (m, BB’ part of AA’BB’ system, 2H, Ar-H), 7.02–7.00 (m, 3H, Ar-H), 5.70 (s, 1H, CH). 13C NMR (100 MHz, CDCl3) δ=150.6, 141.7, 137.4, 137.1, 128.6, 126.5, 93.1, 91.2, 69.4. LC-MS/MS Anal.Calcd. for C16H13I2N2O [M+H]: 502.91118, Found: 502.91223.
2.3.4. (4-Chlorophenyl)(4-(4-chlorophenyl)-1H-imidazol-2-yl)methanol(3d) [24]

Yield; 75%, Color; red solid. m.p: 160-170°C
FT-IR(ATR cm–1): 3148, 2835, 2627, 1609, 1510, 1486, 1448, 1409. 1H-NMR (400 MHz, CDCl3) δ = 12.18 (s, 1H, NH), 7.74–7.72 (m, AA’ part of AA’BB’ system, 2H, Ar-H), 7.53 (s, 1H, CH), 7.47–7.45 (m, AA’ part of AA’BB’ system, 2H, Ar-H), 7.39–7.33 (m, BB’ part of AA’BB’ system, 4H, Ar-H), 6.37 (s, 1H, OH), 5.77 (s, 1H, CH). 13C NMR (100 MHz, CDCl3) δ=151.1, 142.3, 132.2, 130.6, 128.8, 128.7, 128.5, 126.3, 69.2. LC-MS/MS Anal.Calcd. for C16H13CI2N2O [M+H]: 319.03994, Found: 319.04037.
2.3.5. (4-Fluorophenyl)(4-(4-fluorophenyl)-1H-imidazol-2-yl)methanol(3e)

Yield; 73%, Color; pink solid. m.p:155-157°C
FT-IR(ATR cm–1): 3148, 3032, 2835, 2628, 2050, 1980, 1609, 1583, 1565, 1509, 1487, 1445. 1H-NMR (400 MHz, CDCl3) δ = 12.14 (s, 1H, NH), 7.77–7.74 (m, AA’ part of AA’BB’ system, 2H, Ar-H), 7.51–7.48 (m, AA’ part of AA’BB’ system, 2H, Ar-H), 7.46 (s, 1H, CH), 7.17–7.11 (m, BB’ part of AA’BB’ system, 4H, Ar-H), 6.36 (s, 1H, OH), 5.81 (s, 1H, CH). 13C NMR (100 MHz, CDCl3) δ=163.0, 162.4, 160.6, 160.0, 151.2, 139.7, 139.6, 128.8, 126.5, 126.4, 115.7, 115.5, 115.3, 115.0, 69.3. LC-MS/MS Anal.Calcd. for C16H13F2N2O [M+H]: 287.09905, Found: 287.09885.
2.3.6. (4-Bromophenyl)(4-(4-bromophenyl)-1H-imidazol-2-yl)methanol(3f)

Yield; 65%, Color; red solid. m.p: 155–159°C
FT-IR(ATR cm–1): 3139, 2809, 2658, 1716, 1590, 1553, 1514, 1477, 1448, 1406. 1H-NMR (400 MHz, CDCl3) δ = 12.17 (s, 1H, NH), 7.68–7.66 (m, AA’ part of AA’BB’ system, 2H, Ar-H), 7.53–7.46 (m, 5H, Ar-H), 7.40–7.38 (m, BB’ part of AA’BB’ system, 2H, Ar-H), 6.36 (d, J= 3.3 Hz, 1H, OH), 5.75 (d, J= 3.3 Hz, 1H, CH). 13C NMR (100 MHz, CDCl3) δ= 151.0, 142.7, 131.7, 131.4, 129.1, 126.6, 120.7, 119.0, 69.3. LC-MS/MS Anal.Calcd. for C16H13Br2N2O [M+H]: 406.93891, Found: 406.93964.
2.3.7. [1,1’-Biphenyl]-4-yl(4-([1,1’-biphenyl]-4-yl)-1H-imidazol-2-yl)methanol(3g)

Yield; 57%, Color; brown solid. m.p: 255–259°C
FT-IR(ATR cm–1): 3266, 3148, 3055, 3032, 2836, 2621, 2049, 1614, 1583, 1568, 1556, 1510, 1485, 1458, 1444, 1405. 1H NMR (400 MHz, d-DMSO) δ = 12.19 (s, 1H, N-H), 7.84–7.82 (m, 2H, Ar-H), 7.67–7.61 (m, 8H, Ar-H), 7.57–7.54 (m, 2H, Ar-H), 7.45–7.41 (m, 5H, Ar-H), 7.35–7.32 (m, 2H, Ar-H), 6.33 (d, J= 3.2 Hz,1H, OH), 5.85 (d, J= 3.2 Hz, 1H, CH). 13C NMR (100 MHz, d-DMSO) δ= 151.4, 142.6, 140.5, 140.4, 139.5, 137.9, 131.9, 129.6, 129.4, 127.8, 127.6, 127.5, 127.1, 126.9, 126.7, 125.9, 125.2, 69.9. LC-MS/MS Anal.Calcd. for C28H23N2O [M+H]: 403.18049, Found: 403.18079.
2.3.8. Naphthalen-2-yl(4-(naphthalen-2-yl)-1H-imidazol-2-yl)methanol(3h)

Yield; 40%, Color; yellow solid. m.p: 176–180°C
FT-IR(ATR cm–1):3263, 3053, 1718, 1630, 1599, 1507, 1367. 1H NMR (400 MHz, d-DMSO) δ = 12.21 (s, 1H, N-H), 8.23 (s, 1H, Ar-H), 7.92–7.81 (m, 8H, Ar-H), 7.62–7.60 (m, 2H, Ar-H), 7.51–7.44 (m, 4H, Ar-H), 6.39 (s, 1H, OH), 5.98 (s, 1H, CH).13C NMR (100 MHz, d-DMSO) δ= 151.5, 140.9, 128.8, 133.9, 133.2, 132.8, 132.2, 128.3, 128.1, 127.9, 126.6, 126.3, 125.5, 125.1, 124.1, 121.9, 70.3.LC-MS/MS Anal.Calcd. for C24H19N2O [M+H]: 351.14919, Found: 351.14966.
2.3.9. (1H-Imidazol-2-yl)(phenyl)methanol(3i) [26]

Yield; 58%, Color; white solid. m.p: 196–199°C
FT-IR(ATR cm–1): 3163, 3063, 3029, 2891, 2607, 1610, 1584, 1510, 1488,1451. 1H NMR (400 MHz, d-DMSO) δ = 11.86 (s, 1H, N-H), 7.37–7.19 (m, 5H, Ar-H), 6.85 (s, 2H, Ar-H), 6.14 (s, 1H, OH), 5.70 (s, 1H, CH). 13C NMR (100 MHz, d-DMSO) δ= 150.7, 143.7, 128.4, 127.4, 126.8, 70.0. LC/MS-MS Anal.Calcd. for C10H10N2O [M+H]: 175.08659, Found 175.08705.
2.4. General procedure 3
C-2 aroyl substituted imidazolo methanol 3a-h derivatives (1 mmol) were dissolved in dry DCM. Chloroacetylchloride (1 mmol) was added and heated at 45 °C by stirring. It was understood that the reaction was finished after 2 h by TLC method. The reaction flask was filtered and evaporated. Crude product 5a was obtained.
2.4.1. 2,8-Diphenyl-8H-imidazo[2,1-c][1,4]oxazin-6(5H)-one (5a)

Yield; 87%, Color; light yellow viscose.
FT-IR(ATR cm–1): 3148, 2980, 2835, 2639, 1747, 1633, 1601, 1583, 1509, 1486, 1455, 1408, 1342. 1H NMR (400 MHz, CDCl3) δ = 7.83–7.80 (m, 2H, Ar-H), 7.73–7.70 (m, 2H, Ar-H), 7.43 (s, 1H, Ar-H), 7.35 (s, 1H, CH), 7.29–7.25 (m, 6H, Ar-H), 4.64 (AB sistem, J = 15.8 Hz, 1H, CH2a), 4.26 (AB sistem, J= 15.8 Hz, 1H, CH2b). 13C NMR (100 MHz, CDCl3) δ = 166.7, 144.9, 134.1, 133.5, 130.0, 129.7, 129.3, 129.1, 127.7, 125.9, 125.8, 114.1, 70.2, 41.1. LC/MS-MS Anal.Calcd. for C18H14N2O2 [M+H]: 291.11280, Found 291.11392.
2.4.2. 2,8-bis(4-bromophenyl)-8H-imidazo[2,1-c][1,4]oxazin-6(5H)-one(5f)

Yield; 60%, Color; light yellow viscose
FT-IR(ATR cm–1): 3147, 2833, 2635, 1770, 1633, 1593, 1539, 1485, 1440, 1398, 1310. 1H NMR (400 MHz, CDCl3) δ = 7.68 (br, 2H, Ar-H), 7.59 (br, 2H, Ar-H), 7.44–7.40 (m, 6H, Ar-H, imidazole CH and CH), 4.62 (AB sistem, J= 13.7 Hz, 1H, CH2a), 4.30 (AB sistem, J= 13.7 Hz, 1H, CH2b).13C NMR (100 MHz, CDCl3) δ= 166.7, 144.6, 133.4, 132.6, 132.4, 129.3, 127.4, 124.6, 124.2, 114.6, 69.4, 41.0. GC/MS (e/z) Anal.Calcd. for C18H12Br2N2O2: 445.93, Found 445.93.
2.4.3. 2,8-di([1,1’-biphenyl]-4-yl)-8H-imidazo[2,1-c][1,4]oxazin-6(5H)-one(5g)

Yield; 55%, Color; green viscose
FT-IR(ATR cm–1): 3132, 3030, 2833, 2641, 1746, 1633, 1603, 1485, 1471, 106, 1300. 1H NMR (400 MHz, CDCl3) δ = 7.92–7.90 (m, 2H, Ar-H), 7.69–7.62 (m, 3H, Ar-H), 7.51–7.45 (m, 3H, Ar-H), 7.36–7.20 (m, 12H, Ar-H, imidazole CH and CH), 4.64 (AB sistem, J= 14.8 Hz, 1H, CH2a), 4.26 (AB sistem, J= 14.8 Hz, 1H, CH2b).13C NMR (100 MHz, CDCl3) δ= 166.8, 144.8, 142.8, 142.2, 139.6, 139.4, 133.9, 132.3, 128.8, 128.8, 128.2, 127.9, 127.6, 126.9, 126.2, 124.6, 114.2, 70.0, 41.2. GC/MS (e/z) Anal.Calcd. for C30H22N2O2: 442.17, Found 442.17
2.4.4. 8-phenyl-8H-imidazo[2,1-c][1,4]oxazin-6(5H)-one(5i)

Yield; 68%, Color; light yellow viscose
FT-IR(ATR cm–1): 3149, 3059, 2858, 2672, 1766, 1611, 1496, 1456, 1408, 1351. 1H NMR (400 MHz, CDCl3) δ = 7.65–7.64 (m, 2H, Ar-H), 7.34 (m, 2H, Ar-H), 7.30 (s, 1H, CH), 7.26 (m, 1H, Ar-H), 7.18 (s, 2H, Ar-H), 4.59 (AB sistem, J= 15.7 Hz, 1H, CH2a), 4.24 (AB sistem, J= 15.7 Hz, 1H, CH2b). 13C NMR (100 MHz, CDCl3) δ= 166.6, 144.4, 133.3, 130.2, 129.4, 127.6, 118.9, 70.2, 41.0. GC/MS (e/z) Anal.Calcd. for C12H10N2O2: 214.07, Found 214.07
2.4.5. (1-(2-Chloroacetyl)-4-phenyl-1H-imidazol-2-yl)(phenyl)methyl 2-chloroacetate (11a)

Yield; 88%, Color; grey solid. m.p: 138–140°C
FT-IR(ATR cm–1): 3161, 3063, 3034, 2981, 2964, 2940, 1960, 1748, 1606, 1531, 1495, 1450, 1387. 1H NMR (400 MHz, CDCl3) δ = 8.34 (d, J= 0.9 Hz, 1H, Ar-H), 7.81(d, J= 8.1 Hz, 2H, Ar-H), 7.48–7.46 (m, 2H, Ar-H), 7.43–7.36 (m, 5H, Ar-H), 7.32–7.30 (m, 1H, CH), 7.28 (s, 1H, Ar-H), 5.14 (AB sistem, J= 1.2, 15.8 Hz, 2H, CH2), 4.52 (AB sistem, J= 1.2, 15.8 Hz, 2H, CH2). 13C NMR (100 MHz, CDCl3) δ= 167.0, 165.5, 147.6, 136.1, 132.6, 129.2, 129.1, 128.9, 128.9, 128.8, 128.3, 125.4, 115.2, 72.8, 44.7, 41.5. LC/MS-MS Anal.Calcd. for C20H16Cl2N2O3 [M+H]: 403.06107, Found 403.06201.
3. Results
In this study, for starting compounds, C-2 aroyl substituted imidazolo methanol derivatives 3 shown in Scheme 1 were obtained from C-2 aroyl substituted imidazole derivatives 2, which is not found in the literature. The synthesis of 1,4-imidazoxazinone derivatives of C-2 aroyl substituted imidazolo methanol derivative compounds with chloroacetylchloride 13 under the various base and solvent conditions was investigated.
Scheme 1.

C-2 aroyl substituted imidazolo methanol derivatives.
C-2 aroyl substituted imidazolo methanol 3 derivatives were used as starting compound for obtaining 5 or 6 molecules of heterobicyclic imidazoxazinone derivatives. As shown in Scheme 2, cyclization experiments were carried out on reagents using various bases.
Scheme 2.

Heterobicyclic imidazoxazinone derivatives.
Table 1 shows the experiments performed in the presence of various bases, the reagent used, and the starting compound. To abstract the NH and OH protons in the starting compound 3a as in the mechanism given in Scheme 2, when sodium hydride (NaH) is used as a base in DMF, compound 4 formed. However, when compound 13 was added later, neither products 5-6 formation nor starting compound 3a was obtained. No product formation was observed when potassium carbonate (K2CO3) was used as a base in dichloromethane (DCM). The starting product 3a was obtained when the starting compound was made directly with acetic acid (AcOH). We know well from previous studies that 4 intermediate products were formed [27]. As a result of the experiments carried out, it is thought that the compound 13 reagent used has two different ends that can react, and the polymeric structures are formed as a result of the reaction of compound 4 formed by the use of inorganic bases.
Table 1.
Experiments with compound 3a in the presence of various bases.
| Compound | Chloroacetylchloride 13 | Solvent | Base | Temperature | Result | Time (h) | |
|---|---|---|---|---|---|---|---|
| 1 | 3a | 2.8 mmol | DMF | NaH | 0°C | ndb | 24 |
| 2 | 3a | 1 mmol | DCM | K2CO3 | Room Temp. | ndb | 24 |
| 3 | 3a | 1 mmol | AcOH | - | Room Temp. | nra | 24 |
| 4 | 3a | 1.4 mmol | THF | K2CO3 | Room Temp. | ndb | 24 |
nra: No reaction, starting material was recovered. ndb: Non-isolated mixture.
The experiments were concentrated upon obtaining compound 9 from the reaction of compound 13 with the formation of 8 by breaking off the NH proton present in the phenyl (4-phenyl-1H-imidazol-2-il) methanone 7a with various bases shown in Table 2.

Table 2.
Trials to obtain molecule 9.
| Compound | Chloroacetylchloride | Base | Solvent | Temp. | Result | Time (h) | |
|---|---|---|---|---|---|---|---|
| 1 | 7a | 1.4 mmol | NaH (1.6 mmol) | DMF | 0 °C | nra | 24 |
| 2 | 7a | 1.4 mmol | NaH (1.6 mmol) | THF | 0 °C | nra | 24 |
| 3 | 7a | 1.4 mmol | K2CO3 (2.5 mmol) | THF | Reflux | nra | 24 |
| 4 | 7a | 1.4 mmol | K2CO3 (2.5 mmol) | Acetone | Reflux | nra | 24 |
| 5 | 7a | 1.4 mmol | TEA (3 mmol) | THF | Room Temp. | nra | 24 |
| 6 | 7a | 1.4 mmol | - | AcOH | Reflux | nra | 24 |
| 7 | 7a | 1.2 mmol | TEA (3 mmol) | Pyridine | Reflux | nra | 24 |
nra: No reaction, starting material was recovered.
Table 2 shows the experiments with various solvents and bases to remove the 7a NH protons of the imidazole compound. Only the starting compound was recovered from the reaction of the molecule 7a with bases such as NaH, K2CO3, and TEA, with compound 13. In the literature, the NH proton can be easily separated [28–31] with bases such as NaH, K2CO3 and reacted with the appropriate reagent. In the literature, there are some studies in which removal of one of the NH2 protons was done using bases such as NaH, K2CO3 and substitutions with chloroacetylchloride [32–34].
In the studies performed to obtain imidazoxazinone derivatives in Table 3, no product could be isolated in all other trials except 5a, 8, and 9. It might be due to the presence of more than one reacting group on the imidazole ring, and the presence of two reagent ends in compound 13. At the same time, it may have caused the formation of different polymeric structures. After this observation, crude NMR was obtained without extraction in all our other trials except 8 and 9 in Table 3. In NMR analysis, the formation of 5a, the molecule we aimed in reactions 1, 2, 5, 6, and 7, was determined. Due to the isolation problems arising from the lactone structure of the molecule 5a, the peaks of compound 13, which is overused with the 5a molecule, were also observed. In the reaction where compound 13 was used at 1/1 stereometric coefficients (Scheme 3), it was observed that molecule 5a was synthesized purely without using a base, and there was no chemical shift of molecule 13. Using the base molecule 13 with a 1/1 stichiometric coefficient, a mixture of molecules was observed, which was not understood in crude NMR. In the reaction conditions obtained by taking crude NMR, it was determined that when the reaction medium was heated at 45 °C in dry DCM for 2 h without using base, high purity targeted molecule was synthesized without leaving starting compounds 3a and 13.
Scheme 3.

Preparation of imidazoxazinone derivatives.

Table 3.
Synthesis of imidazoxazinone molecule.
| Compound | Chloroacetylchloride | Base | Solvent | Temp. | Result | Time | |
|---|---|---|---|---|---|---|---|
| 1 | 3a | 1.4 mmol | - | THF | 45 °C | 5a | 15 min |
| 2 | 3a | 1.4 mmol | - | DCM | Room Temp. | 5a | 2 h |
| 3 | 3a | 1.4 mmol | TEA | DCM | Room Temp. | 11 or 12 | 2 h |
| 4 | 3a | 1 mmol | TEA | DCM | Room Temp. | ndb | 1 h |
| 5 | 3a | 1.4 mmol | NaHCO3 | MeCN | Room Temp. | 5a | 30 min |
| 6 | 3a | 1 mmol | - | DCM | 45° | 5a | 2 h |
| 7 | 3a | 1 mmol | - | THF | Room Temp. | 5a and 3a (1/3) | 2 h |
| 8 | 3a | 1 mmol | - | AcOH | Room Temp. | 3a | 24 h |
| 9 | 3a | 1 mmol | - | THF | 45°C | ndb | 2 h |
ndb: Non-isolated mixture.
Various cyclization trials were carried out under the reaction conditions shown in Table 3 to obtain imidazoxazinone derivatives, as shown in Scheme 3. As a result, it was observed that the product formed in the reaction of compound 3a and compound 13 in DCM solvent at a ratio of 1: 1 at 45 °C was imidazoxazinone derivative is compound 5.
In the reaction without the use of a base, it was thought that the OH group would react with the acyl carbonyl [35] and substitute the chloroacetylchloride compound on oxygen, and then the molecule would be cyclized by cleaving the NH proton in the imidazole compound with the appropriate base. As predicted, it was observed that the reaction started when the OH group in the imidazole molecule attacked the electrophilic acyl carbonyl of compound 13, and the compound 5a was formed in the solvent medium without using any base as a result of the attack of the second electrophilic group of compound 13 to the methyl chloride with the unshared electron pair of the NH nitrogen in the imidazole through the resonance that occurred in the molecule. It was determined that the 5a molecule was not degraded by NMR taken at certain intervals within a month. However, introducing a nucleophile such as water, alcohol, etc. causes the molecule to react rapidly.
When the 1H-NMR spectrum is examined over the 5a compound shown in Figure 3, it is seen that the protons of the C5 carbon atom are resonant at 4.26 CH2b and 4.64 CH2a ppm. It is understood from the spectrum that these protons are diastereotopic, interacting with each other, and are part of an AB system. When the interactions of these protons were examined, the interaction value was measured as J= 15.8 Hz. It is understood from this value that these protons are in the geminal position, and neighboring groups with these protons have π orbitals [36]. It is in harmony with this information in the molecular structure we propose. The proton of the C8 carbon resonated as a singlet at 7.35 ppm due to its electronic environment. When the HSQC spectrum is examined, it has been confirmed that the protons resonating at 4.26 and 4.64 ppm are geminal protons and are bound to the same carbon. It is seen that protons resonating at 4.26 to 4.64 ppm are C5 paired with the resonant carbon at 41.1 ppm. On the other hand, it has been confirmed from the HSQC spectrum that the proton resonating in the aromatic field is an aliphatic proton that the C8 carbon atom protons do not belong to any aromatic system. It was observed that the proton resonant at 7.43 ppm belongs to the resonant carbon C8 at 70.1 ppm. It is seen that the lactone carbonyl carbon of the imidazoxazinone compound is C6 resonant at 166 ppm and C9, C2, and C3 carbon atoms are resonant at 144.9, 134.1, and 114.0 ppm, respectively.
Figure 3.

Imidazoxazinone derivative 5a.
4. Conclusion
In this work, nine different C-2 aroyl imidazole derivatives were synthesized, and C-2 aroyl substituted imidazolo methanol derivative compounds were obtained as the starting compound in the yield of imidazoxazinone derivatives with suitable reducers. Then, the synthesis of 1,4-imidazoxazinone derivatives with chloroacetylchloride under the various base and solvent conditions was investigated. As a result of the obtained imidazo methanol derivatives and the substitution reaction and ring closure reactions, the synthesis of 1,4 imidazoxazinone derivatives and dichloraacetylchloride derivative molecules was carried out. Structure characterizations for the obtained compound 5 were elucidated by using 1H-NMR, 13C-NMR, and LC-MS / MS.
Supporting information
1H-NMR, 13C-NMR, HSQC, APT spectrum and LC-MS / MS, GC-MS data are provided in the Supplementary Material section of this article.
Acknowledgement and/or disclaimers, if any
Authors thank to Van Yüzüncü Yil University (grand number: FBA-2019-8405) for financial support and Science Research and Applied Center for their research laboratories and spectral analysis.
References
- Schröder K Enthaler S Bitterlich B Schulz T Spannenberg A Design of and Mechanistic Studies on a Biomimetic Iron–Imidazole Catalyst System for Epoxidation of Olefins with Hydrogen Peroxide. Chemistry A European Journal. 2009;38:5471–5481. doi: 10.1002/chem.200802731. [DOI] [PubMed] [Google Scholar]
- The Royal Society of Chemistry. 2011;28:1143–1191. [Google Scholar]
- Gao G Xiao R Yuan Y Zhou C You J Efficient imidazolium catalysts for the benzoin Condensation. Journal of Chemical Research. 2002;10:262–263. [Google Scholar]
- Farooq S UlHaq I Ullah N. Synthesis, characterization and biological evaluation of N-Mannich base derivatives of 2-phenyl-2-imidazoline as potential antioxidants, enzyme inhibitors, antimicrobials, cytotoxic and anti-inflammatory agents. Arabian Journal of Chemistry. 2021;14:103050–103050. [Google Scholar]
- Mazik M Hartmann A. Recognition properties of receptors consisting of imidazole and indole recognition units towards carbohydrates. Beilstein Journal of Organic Chemistry. 2010;6:1–10. doi: 10.3762/bjoc.6.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choi J-H Abe N Tanaka H Fushimi K Nishina Y Plant-Growth Regulator Produced by the Fairy Ring Forming Fungus Lepista sordida. Journal of Agricultural and Food Chemistry. 2010;58:9956–9959. doi: 10.1021/jf101619a. [DOI] [PubMed] [Google Scholar]
- Emandia G Flanagana KJ Sengea MO Fluorescent imidazole-based chemosensors for the reversible detection of cyanide and mercury ions. Photochemical & Photobiological Sciences. 2018;17:1450–1461. doi: 10.1039/c8pp00226f. [DOI] [PubMed] [Google Scholar]
- LinLing Z Review on supermolecules as chemical drugs. Science in China Series B: Chemistry. 2009;52:415–458. doi: 10.1007/s11426-009-0103-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Niedzicki L Zukowska G.Z Bukowskaa M Szczecinski P Grugeonb S New type of imidazole based salts designed specifically for lithium ion batteries. Electrochimica Acta. 2010;10:1450–1454. [Google Scholar]
- Jacques P Graff B Diemer V Ay E Chaumeil H Negative solvatochromism of a series of pyridinium phenolate betaine dyes with increasing steric hindrance. Chemical Physics Letters. 2012;531:242–246. [Google Scholar]
- Fu N Zhang L Luo S Chenga J-P Chiral primary amine catalysed asymmetric conjugate addition of azoles to α-substituted vinyl ketones. Organic Chemistry Fronttiers. 2014;1:68–72. [Google Scholar]
- Taşdemir V Kuzu B Tan M Genç H Menges N. Copper-Catalyzed Synthesis of Fused Imidazopyrazine N-Oxide Skeletons Synlett. 2019;30:307–311. [Google Scholar]
- Calvino-Casilda V Banares MA In situ Raman monitoring of Michael addition for the synthesis of 1-substituted imidazoles intermediates with antiviral properties. Catalysis Today. 2012;187:191–194. [Google Scholar]
- Mombelli PL Chapelain C Munzinger N Joliat E İllarionov B Imidazole-and Benzimidazole-Based Inhibitors of the IspE: Targeting the Substrate-Binding Site and the Triphoshate-Binding Loop of the ATP Site. European Journal of Organic Chemistry. 2013;10:1068–1079. [Google Scholar]
- Kuzu B Tan M Ekmekci Z Menges N. A novel structure for ESIPT emission: Experimental and theoretical İnvestigations. Journal of Photochemistry & Photobiology A: Chemistry. 2019;381:11874–11874. [Google Scholar]
- Zhang L Peng X Damu GLV Geng R Zhou C-He. Medicinal Research Reviews. 2014;34:340–437. doi: 10.1002/med.21290. [DOI] [PubMed] [Google Scholar]
- Tippannanavar M Verma A Kumar R Gogoi R Kundu A Preparation of nanofungicides based on imidazole drugs and their antifungal evaluation. Journal of Agricultural and Food Chemistry. 2020;68:4566–4578. doi: 10.1021/acs.jafc.9b06387. [DOI] [PubMed] [Google Scholar]
- Nagaraj M Muthusubramanian S Transition base-promoted hydroalkoxylation: Synthesis of Substituted imidazo[2. 2016;1:oxazines–oxazines. [Google Scholar]
- Kuzu B Genc H Taspinar M Tan M Menges N. An easy synthetic protocol for imidazo-1,4-oxazines and evaluation of their toxicities. Heteroatom Chemistry. 2018;29:1–12. [Google Scholar]
- Ashtekar DR C-Perira R Nagrajan K Vishvanathan N Bhatt AD In vitro and in vivo activities of the nitroimidazole cgi 17341 against mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 1993;37:183–186. doi: 10.1128/aac.37.2.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eftekhari-Sis B Zirak M Akbari A Chemical Reviews. 2013;113:2958–3043. doi: 10.1021/cr300176g. [DOI] [PubMed] [Google Scholar]
- Khalili B Jajarmi P Eftekhari-Sis B Hashemi MM Novel one-pot, three-component synthesis of new 2-Alkyl-5-aryl- The Journal of Organic Chemistry. 1H;73:2090–2095. doi: 10.1021/jo702385n. [DOI] [PubMed] [Google Scholar]
- Eftekhari-Sis B Akbari1 A Amirabedi M. Aryl -Diaryl- -Pyrrol- Synthesis of new N-Alkyl( Chemistry of Heterocyclic Compounds. 2010;2:4–4. [Google Scholar]
- Mirko R Manoj K. P Alberto R sodium channel blocking activity and in-vivo testing of new phenylimidazole derivatives. Letters in Drug Design and Discovery. 2016;13:962–967. [Google Scholar]
- Kuzu B Tan M Taslimi P Gülçin İ Taşpınar M Mono- or di-substituted imidazole derivatives for inhibition of acetylcholine and butyrylcholine esterases. Bioorganic Chemistry. 2019;86:187–196. doi: 10.1016/j.bioorg.2019.01.044. [DOI] [PubMed] [Google Scholar]
- Martinez R Pastor M.I Yus M. -Functionalized imidazoles as palladium ligands: an efficient and robust catalytic system for the fluorine-free hiyama reaction. European Journal of Organic Chemistry. 1;10:872–877. [Google Scholar]
- Alkene or Alkyne-linked Imidazole Derivatives and Investigation of Their Applications. İn: 7th Drug Chemistry Conference: Design, Synthesis, Production and Standardization of Drug Active Substances. 2019.
- Mishra D Singh R Rout C. A facile amidation of chloroacetyl chloride using DBU. International Journal of ChemTech Research. 2017;10:365–372. [Google Scholar]
- Choi J Lee J-O Kim M-S Nam SJEN Chun K-H. Preparation Chloride Chloroacetyl -one Derivatives by Cyclization Reaction between N-Bts Amino Alcohol. -one and 1. 2008;29:4–4. [Google Scholar]
- Gao B Wang L Du R Studies on Chloroacylation Reaction Process of Crosslinked Polystyrene Microspheres with ω- Chloroacyl Chloride as Reagent. Journal of Macromolecular Science Part A: Pure and Applied Chemistry. 2010;47:927–934. [Google Scholar]
- Kiamehr M Moghaddam FM Erami MS A convenient synthesis of 3-formyl-2-thioacetamide-indole derivatives via the one-pot reaction of indolin-2-thiones, isocyanides and chloroacetylchloride. Tetrahedron Letters. 2015;56:7190–7192. [Google Scholar]
- Sing K.S Manne N Pal M. Synthesis of (S)-1-(2-chloroacetyl)pyrrolidine-2- carbonitrile: A key intermediate for dipeptidyl peptidase IV inhibitors. Beilstein Journal of Organic Chemistry. 2008;4:1–5. doi: 10.3762/bjoc.4.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Viktor V. Efimov V.V Krasnov P.O Lyubyashkin A.V Suboch G. A et al. Journal of Molecular Structure. 2018;1165:370–375. [Google Scholar]
- Fikry R Ismail N Raslan S El-Tahawe H Synthesıs and Reactions of New Pyrazole Derivatives. European Chemical Bulletin. 2016;5:157–162. [Google Scholar]
- Toma T Shimokawa J Fukuyama T. N A Convenient Reagent for Facile Synthesis of Diazoacetates. Organic Letters. 2007;9:3195–3197. doi: 10.1021/ol701432k. [DOI] [PubMed] [Google Scholar]
- 2004.
